Scarica l'app Stockscreener
4.62
3.12%
0.14
Dopo l'orario di chiusura:
4.61
-0.010
-0.22%
Precedente Chiudi:
$4.48
Aprire:
$4.43
Volume 24 ore:
379.13K
Relative Volume:
0.81
Capitalizzazione di mercato:
$81.60M
Reddito:
-
Utile/perdita netta:
$-30.54M
Rapporto P/E:
-2.9806
EPS:
-1.55
Flusso di cassa netto:
$-18.30M
1 W Prestazione:
-2.74%
1M Prestazione:
-0.22%
6M Prestazione:
+625.16%
1 anno Prestazione:
+710.81%
Intervallo 1D:
$4.28
$4.66
Intervallo di 1 settimana:
$4.28
$4.7641
Portata 52W:
$0.4139
$8.2457
Unicycive Therapeutics Inc Stock (UNCY) Company Profile
Nome
Unicycive Therapeutics Inc
Settore
Industria
Telefono
650-384-0642
Indirizzo
4300 EL CAMINO REAL, SUITE 210, LOS ALTOS
Confronta UNCY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
UNCY
Unicycive Therapeutics Inc
|
4.62 | 79.12M | 0 | -30.54M | -18.30M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
409.47 | 105.61B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
657.53 | 67.99B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
442.70 | 58.19B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
854.65 | 52.40B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.70 | 39.60B | 447.02M | -1.18B | -906.14M | -6.1812 |
Unicycive Therapeutics Inc Stock (UNCY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-21 | Iniziato | Guggenheim | Buy |
| 2024-04-04 | Iniziato | Piper Sandler | Overweight |
Unicycive Therapeutics Inc Borsa (UNCY) Ultime notizie
How rising interest rates impact Unicycive Therapeutics Inc. stockNew Guidance & AI Driven Stock Movement Reports - newser.com
How Unicycive Therapeutics Inc. stock compares to growth peersQuarterly Trade Summary & Fast Gain Swing Alerts - newser.com
What catalysts could drive Unicycive Therapeutics Inc. stock higherPortfolio Update Report & Breakout Confirmation Trade Signals - newser.com
What moving averages say about Unicycive Therapeutics Inc.CPI Data & Proven Capital Preservation Methods - newser.com
Sentiment analysis tools applied to Unicycive Therapeutics Inc.2025 Support & Resistance & Risk Controlled Swing Alerts - newser.com
CEO Change: How rising interest rates impact Unicycive Therapeutics Inc. stockWeekly Stock Recap & Verified Chart Pattern Signals - fcp.pa.gov.br
Will Unicycive Therapeutics Inc. stock deliver shareholder value2025 Bull vs Bear & Real-Time Price Movement Reports - fcp.pa.gov.br
Live market analysis of Unicycive Therapeutics Inc.July 2025 News Drivers & Weekly Chart Analysis and Trade Guides - newser.com
Can Unicycive Therapeutics Inc. stock hit analyst price targetsMarket Performance Report & Daily Stock Momentum Reports - newser.com
Is Unicycive Therapeutics Inc. stock oversold or undervaluedTrade Entry Report & Low Risk High Win Rate Stock Picks - fcp.pa.gov.br
Unicycive Therapeutics (UNCY) Projected to Post Earnings on Wednesday - MarketBeat
Should you hold or exit Unicycive Therapeutics Inc. now2025 Big Picture & Precise Entry and Exit Recommendations - newser.com
Does Unicycive Therapeutics Inc. show high probability of reboundDip Buying & Smart Allocation Stock Reports - newser.com
How Unicycive Therapeutics Inc. stock performs in interest rate cyclesRate Cut & Fast Entry Momentum Alerts - newser.com
Analyzing net buyer seller activity in Unicycive Therapeutics Inc.Quarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Will Unicycive Therapeutics Inc. stock beat EPS estimates2025 Sector Review & Low Risk High Win Rate Picks - newser.com
Why Unicycive Therapeutics Inc. stock remains resilientJuly 2025 Volume & Trade Opportunity Analysis Reports - newser.com
Unicycive Therapeutics, Inc. (UNCY) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Is Unicycive Therapeutics Inc. meeting your algorithmic filter criteriaPortfolio Gains Summary & Free Safe Entry Trade Signal Reports - newser.com
Can Unicycive Therapeutics Inc. stock sustain institutional interestProduct Launch & Stepwise Trade Signal Implementation - newser.com
Can Unicycive Therapeutics Inc. stock rebound after recent weaknessMarket Performance Summary & Weekly Top Stock Performers List - fcp.pa.gov.br
Unicycive Therapeutics, Inc. (UNCY) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Unicycive Therapeutics, Inc. (UNCY) Stock Price, News, Quote & History - Yahoo! Finance Canada
Unicycive Therapeutics price target raised to $22 from $9 at H.C. Wainwright - MSN
Why Unicycive Therapeutics Inc. stock could rally in 2025Market Weekly Review & Daily Volume Surge Trade Alerts - fcp.pa.gov.br
Unicycive Therapeutics to Participate in a Fireside Chat at - GlobeNewswire
Unicycive Therapeutics Inc Azioni (UNCY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.44%
0.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):